Demand for medical marijuana in Germany is surging, substantiating the thesis of Canadian companies positioning themselves to meet a supply shortfall there.
The three insurance firms – Allgemeine Ortskrankenkasse, Barmer and Techniker Krankenkasse – told the newspaper they approved MMJ applications for about two-thirds of the applicants.
Failing to receive insurance coverage leaves patients on the hook for the cost of the prescribed medicine.
The newspaper estimated those costs ranged from 140 to 1,800 euros ($160 to $2,100) per month.
Every German citizen is mandated to have health coverage through a private company, and some insurance firms offer MMJ in their plans — making medical cannabis accessible to the country’s 70 million insured people.